Myriad Genetics is set to share information about guarded BRCA variants in a public database, marking a significant shift in the company’s approach to sharing genetic information. Previously, the company had been criticized for guarding such information and limiting access to it, even in cases where the information could be critical in making treatment decisions for patients. The move has been welcomed by experts as an important step towards greater transparency and collaboration in the field of genetics.
Read the full article here.
The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.
My Gene Counsel ©